Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

Top Story Archived • April 18, 2026 • 2 views

President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."

Source: https://feeds.feedburner.com/foxnews/latest - Read Original

FB X ✉️

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!